Fc-ANTIBODY FRAGMENT HAVING HIGH BINDING AFFINITY TO FcγRIIB Russian patent published in 2025 - IPC C07K16/00 C07K16/28 C07K14/705 A61K39/395 A61P35/00 

Abstract RU 2839694 C1

FIELD: biotechnology.

SUBSTANCE: invention relates to biotechnology, in particular to a mutant polypeptide Fc-fragment having properties of high binding affinity to FcgRIIB and having an amino acid sequence corresponding to residues from position 233 to position 332 of the Fc region of human IgG2 in accordance with EU numbering, as well as to a mutant Fc region of immunoglobulin, having properties of high binding affinity to FcgRIIB and having an amino acid sequence from position 231 to the carboxyl end of heavy chains of human IgG2 in accordance with EU numbering. Also disclosed is the use of a mutant polypeptide Fc-fragment or mutant Fc-region of immunoglobulin for constructing agonist activity of antibodies or fused proteins, an isolated polynucleotide, an expression vector, host cell, pharmaceutical composition, methods of producing mutant polypeptide Fc-fragment and mutant Fc-region of immunoglobulin and the use of the mutant polypeptide Fc-fragment and the mutant Fc-region of the immunoglobulin in the manufacture of a pharmaceutical composition having high agonist activity of the antibody or fusion protein.

EFFECT: invention has important application in optimization of antibody agonist activity.

13 cl, 17 dwg, 14 tbl, 11 ex

Similar patents RU2839694C1

Title Year Author Number
HYBRID PROTEINS OF HUMAN PROTEIN FRAGMENTS TO CREATE ORDERED MULTIMERIZED COMPOSITIONS OF IMMUNOGLOBULIN FC REGIONS WITH ENHANCED BINDING WITH A COMPLEMENT SYSTEM 2016
  • Block, David S.
  • Olsen, Henrik
RU2737378C2
HYBRID PROTEINS OF HUMAN PROTEIN FRAGMENTS FOR CREATING ORDERLY MULTIMERIZED COMPOSITIONS OF Fc REGIONS OF IMMUNOGLOBULINS WITH ENHANCED BINDING TO COMPLEMENT SYSTEM 2016
  • Block, David S.
  • Olsen, Henrik
RU2837284C2
HYBRID PROTEINS OF sPD-1-Fc VARIANT 2019
  • Giaccia, Amato J.
  • Aguilera, Todd A.
  • Kariolis, Mihalis S.
  • Miao, Yu
  • Thakkar, Kaushik
  • Zhang, Xin Eric
RU2785993C2
MUTANT VARIANTS OF Fc IgG1 DEVOID OF EFFECTOR FUNCTIONS 2018
  • Brak, Simon Sebastyan
  • Attinger-Toller, Izabella
  • Biller, Fabian
  • Grabulovski, Dragan
  • Bertsinger, Yulian
  • Zumsteg, Adrian
RU2764559C2
ANTI-PCSK9 ANTIBODY, ITS ANTIGEN-BINDING DOMAIN AND MEDICAL APPLICATION THEREOF 2016
  • Tsyuj, Syandun
  • E, Sin
  • Syuj, Shaoyu
  • Yuan, Bej
  • Tsuj, Dunbin
  • Khu, Tsiyue
  • Chzhan, Lej
  • Syuj, Chzhibin
  • Tao, Vejkan
  • Chzhan, Lyanshan
  • Sun, Pyaoyan
RU2739208C2
ENGINEERED MULTI-SPECIFIC ANTIBODIES AND OTHER MULTIMERIC PROTEINS WITH ASYMMETRIC MUTATIONS IN THE CH2-CH3 REGION 2018
  • Chiu, Mark
  • Zvolak, Adam
RU2804031C2
Therapeutic antibodies to CD47 2016
  • Manning, Pamela
  • Pyuro, Robin
  • Almagro, Khuan, K.
  • Karr, Robert, U.
RU2748401C2
METHOD OF PRODUCING VARIANTS OF FCYRIIB-SPECIFIC FC-REGION 2013
  • Katada Khitosi
  • Kadono Sodziro
  • Mimoto Futa
  • Igava Tomoyuki
RU2820161C1
VERSIONS OF FCΓRIIB-SPECIFIC FC-REGION 2013
  • Katada Khitosi
  • Kadono Sodziro
  • Mimoto Futa
  • Igava Tomoyuki
RU2729831C2
METHODS OF COMBINED TREATMENT OF MALIGNANT NEOPLASMS, INCLUDING AGENTS BLOCKING CTLA-4 AND PD-1 2020
  • Lafejs, Drejk
  • Punnonen, Yukha
  • Bauman, Edvard
  • Bosh, Devid
  • Chekerian, Alissa
  • Grejn, Dzheffri
  • Mauze, Smita
  • Savant, Anandi
  • Annamalai, Lakshmanan
RU2833523C2

RU 2 839 694 C1

Authors

Li Fubin

Zhang Yan

Zhang Mi

Bi Yanxia

Tian Shihao

Zhang Huihui

Liu Shujun

Dates

2025-05-12Published

2020-12-03Filed